These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 1913658

  • 1. Experimental studies and preliminary clinical trial of vinorelbine-loaded polymeric bioresorbable implants for the local treatment of solid tumors.
    Fournier C, Hecquet B, Bouffard P, Vert M, Caty A, Vilain MO, Vanseymortier L, Merle S, Krikorian A, Lefebvre JL.
    Cancer Res; 1991 Oct 01; 51(19):5384-91. PubMed ID: 1913658
    [Abstract] [Full Text] [Related]

  • 2. Paclitaxel, carboplatin, and vinorelbine in the treatment of advanced non-small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network.
    Hainsworth JD, Burris HA, Morrissey LH, Thomas M, Erland JB, Butts JA, Joseph G, Kalman L, Greco FA.
    Cancer J; 2000 Oct 01; 6(3):151-6. PubMed ID: 10882330
    [Abstract] [Full Text] [Related]

  • 3. Vinorelbine (Navelbine), cisplatin, and concomitant radiation therapy for advanced malignancies of the chest: a Phase I study.
    Vokes EE, Haraf DJ, Masters GA, Hoffman PC, Drinkard LC, Ferguson M, Olak J, Watson S, Golomb HM.
    Semin Oncol; 1996 Apr 01; 23(2 Suppl 5):48-52. PubMed ID: 8610237
    [Abstract] [Full Text] [Related]

  • 4. A phase II study of cisplatin, 5-fluorouracil, and leucovorin augmented by vinorelbine (Navelbine) for advanced non-small cell lung cancer: rationale and study design.
    Vokes EE, Drinkard LC, Samuels BL, Hoffman PC, Watson S, Bitran JD, Haraf DJ, Ferguson MF, Golomb HM.
    Semin Oncol; 1994 Oct 01; 21(5 Suppl 10):79-83; discussion 83-4. PubMed ID: 7973772
    [Abstract] [Full Text] [Related]

  • 5. Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer.
    Masters GA, Hoffman PC, Drinkard LC, Watson S, Samuels BL, Golomb HM, Vokes EE.
    Semin Oncol; 1996 Apr 01; 23(2 Suppl 5):11-8. PubMed ID: 8610230
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Vinorelbine and 5-fluorouracil bolus and/or continuous venous infusion plus levofolinic acid as second-line chemotherapy for metastatic breast cancer: an analysis of results in clinical practice of the Gruppo Oncologico Italia Meridionale (GOIM).
    Gebbia V, Caruso M, Borsellino N, Ajello R, Tirrito ML, Chiarenza M, Valenza R, Verderame F, Varvara F, Marrazzo A, Bajardi E, Ferrao F, Bordonaro R, Tralongo P.
    Anticancer Res; 2006 Apr 01; 26(4B):3143-50. PubMed ID: 16886648
    [Abstract] [Full Text] [Related]

  • 9. Five-day infusion of fluorouracil and vinorelbine for advanced breast cancer patients treated previously with anthracyclines.
    Pieńkowski T, Jagiello-Gruszfeld A.
    Int J Clin Pharmacol Res; 2001 Apr 01; 21(3-4):111-7. PubMed ID: 12067140
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Polymer chemotherapy for head and neck cancer.
    Shikani AH, Domb AJ.
    Laryngoscope; 2000 Jun 01; 110(6):907-17. PubMed ID: 10852503
    [Abstract] [Full Text] [Related]

  • 12. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G, Marschke R, Camoriano JK, Sorensen JM, Sloan JA, Richardson RL.
    Cancer J Sci Am; 1997 Jun 01; 3(5):297-302. PubMed ID: 9327154
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Multidisciplinary therapy of locally far-advanced or inflammatory breast cancer with fixed perioperative sequence of epirubicin, vinorelbine, and Fluorouracil chemotherapy, surgery, and radiotherapy: long-term results.
    Ardavanis A, Scorilas A, Tryfonopoulos D, Orphanos G, Missitzis I, Karamouzis M, Chrysochoou M, Sotiropoulou A, Arnogiannaki N, Ioannidis G, Pissakas G, Rigatos G.
    Oncologist; 2006 Jun 01; 11(6):563-73. PubMed ID: 16794236
    [Abstract] [Full Text] [Related]

  • 16. Vinorelbine (Navelbine)--a new agent for the treatment of non-small cell lung cancer: a summary.
    Coltman CA.
    Semin Oncol; 1994 Oct 01; 21(5 Suppl 10):1-3. PubMed ID: 7973763
    [Abstract] [Full Text] [Related]

  • 17. A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer.
    Masters GA, Drinkard LC, Hoffman PC, Lane N, Watson S, Samuels BL, Bitran JD, Golomb HM, Vokes EE.
    Cancer J Sci Am; 1995 Oct 01; 1(4):288-94. PubMed ID: 9166490
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Toxicology and carcinogenesis studies of indium phosphide (CAS No. 22398-90-7) in F344/N rats and B6C3F1 mice (inhalation studies).
    National Toxicology Program.
    Natl Toxicol Program Tech Rep Ser; 2001 Jul 01; (499):7-340. PubMed ID: 12087422
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.